Should urinary CXCL10/creatinine be measured for kidney transplantation?

A study published in the journal Pediatric Transplantation explores the use of urinary CXCL10/creatinine ratio as a biomarker for kidney transplantation. The study analyzed urine samples from 72 pediatric kidney transplant recipients and found that urinary CXCL10/creatinine ratio was significantly higher in samples with allograft rejection compared to those without rejection. However, the authors note that further research is needed before this biomarker can be implemented in clinical practice. The study highlights the importance of identifying and validating new biomarkers for kidney allograft function. [Extracted from the article]